$9.00 -0.15 (-1.64%)
2/10/2012 4:00 PM

EXACT Sciences Corp (NASDAQ:EXAS)

CAPS Rating: 2 out of 5

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

Featured Broker Partners


Advertisement